Scientific article
English

Preventive administration of UDCA after liver transplantation for primary biliary cirrhosis is associated with a lower risk of disease recurrence

Published inJournal of hepatology, vol. 63, no. 6, p. 1449-1458
Publication date2015
Abstract

Recurrence of primary biliary cirrhosis (PBC) after liver transplantation (LT) is not rare and can occasionally lead to severe graft dysfunction and retransplantation. Ursodeoxycholic acid (UDCA) is a safe and effective treatment for PBC. However, whether preventive administration of UDCA after LT could lower the incidence of PBC recurrence is unknown.

Citation (ISO format)
BOSCH, Alexie et al. Preventive administration of UDCA after liver transplantation for primary biliary cirrhosis is associated with a lower risk of disease recurrence. In: Journal of hepatology, 2015, vol. 63, n° 6, p. 1449–1458. doi: 10.1016/j.jhep.2015.07.038
Main files (1)
Article (Accepted version)
accessLevelRestricted
Identifiers
Journal ISSN0168-8278
594views
0downloads

Technical informations

Creation15/01/2016 08:24:00
First validation15/01/2016 08:24:00
Update15/03/2023 00:09:07
Status update15/03/2023 00:09:06
Last indexation31/10/2024 02:47:15
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack